NCT07478601

Brief Summary

Postoperative pulmonary dysfunction is frequently observed after laparoscopic abdominal surgery due to the combined effects of general anesthesia, pneumoperitoneum, diaphragmatic dysfunction, and postoperative pain. These factors may impair respiratory mechanics, reduce lung volumes, and negatively affect postoperative recovery. Effective postoperative analgesia plays a crucial role in preserving respiratory function by allowing adequate ventilation and reducing pain-related respiratory limitation. The erector spinae plane (ESP) block is a relatively novel ultrasound-guided fascial plane block that provides thoracoabdominal analgesia through the spread of local anesthetic along the paraspinal fascial planes. By reducing postoperative pain and opioid consumption, ESP block may contribute to improved respiratory mechanics and preservation of postoperative pulmonary function. The aim of this prospective randomized controlled study is to evaluate the effect of ultrasound-guided erector spinae plane block on postoperative respiratory function and pain in patients undergoing elective laparoscopic cholecystectomy. Patients will be randomized into two groups: an ESP block group receiving bilateral ultrasound-guided erector spinae plane block and a control group receiving standard analgesic management. Postoperative respiratory parameters will be evaluated using spirometry measurements including forced expiratory volume in one second (FEV1), forced vital capacity (FVC), the FEV1/FVC ratio, and forced expiratory flow at 25-75% of the pulmonary volume (FEF25-75). In addition, arterial blood gas parameters and postoperative pain scores will be assessed and compared between the groups. The study aims to determine whether ultrasound-guided erector spinae plane block improves postoperative respiratory function and contributes to better postoperative recovery in patients undergoing laparoscopic cholecystectomy.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started May 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 24, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2027

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 12, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

CholelithiasisErector Spinae Plane BlockPostoperative Respiratory FunctionLaparoscopic CholecystectomyPostoperative PainRegional AnesthesiaSpirometry

Outcome Measures

Primary Outcomes (2)

  • Change in Forced Expiratory Volume in 1 Second (FEV1)

    Postoperative respiratory function will be assessed by spirometry measurement of forced expiratory volume in 1 second (FEV1). Changes in FEV1 from baseline will be compared between the ultrasound-guided erector spinae plane block group and the control group in patients undergoing elective laparoscopic cholecystectomy.

    Preoperative, postoperative 6 hours, and postoperative 24 hours

  • Change in Forced Vital Capacity (FVC)

    Forced vital capacity (FVC) will be measured by spirometry to evaluate postoperative respiratory function. Changes in FVC from baseline will be compared between the erector spinae plane block group and the control group.

    Preoperative baseline, postoperative 6 hours, and postoperative 24 hours

Secondary Outcomes (5)

  • Change in FEV1/FVC Ratio

    Preoperative baseline, postoperative 6 hours, and postoperative 24 hours

  • Change in Forced Expiratory Flow 25-75% (FEF25-75)

    Preoperative baseline, postoperative 6 hours, and postoperative 24 hours

  • Change in Arterial Blood Gas Parameters

    Preoperative baseline and postoperative 6 hours

  • Postoperative Pain Intensity (VAS)

    Postoperative 1 hour, 6 hours, and 24 hours

  • Postoperative Analgesic Consumption

    Within the first 24 hours after surgery

Study Arms (2)

ESP Block Group

EXPERIMENTAL

Patients undergoing elective laparoscopic cholecystectomy who will receive bilateral ultrasound-guided erector spinae plane block in addition to standard general anesthesia for postoperative analgesia.

Procedure: Erector Spinae Plane Block

Control Group

NO INTERVENTION

Patients undergoing elective laparoscopic cholecystectomy who will receive standard general anesthesia and postoperative analgesic management without erector spinae plane block.

Interventions

Ultrasound-guided bilateral erector spinae plane block performed at the thoracic level following induction of general anesthesia to provide postoperative thoracoabdominal analgesia.

ESP Block Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years ASA physical status I-III-- III Patients scheduled for elective laparoscopic cholecystectomy under general anesthesia Ability to perform spirometry tests Provision of written informed consent

You may not qualify if:

  • Patient refusal to participate Chronic pulmonary disease (e.g., COPD, asthma, restrictive lung disease) Morbid obesity (BMI ≥ 35 kg/m²) Coagulopathy or anticoagulant therapy Local infection at the block site Allergy to local anesthetic agents Pregnancy Previous thoracic surgery Neuromuscular disease affecting respiratory function Conversion from laparoscopic to open surgery Inability to perform postoperative spirometry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa Uludağ University Faculty of Medicine Hospital

Bursa, Bursa, 16059, Turkey (Türkiye)

Location

MeSH Terms

Conditions

CholelithiasisPain, Postoperative

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Selcan Akesen, Assoc. Prof. MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors will be blinded to group allocation. The erector spinae plane block will be performed by an anesthesiologist who will not participate in postoperative data collection or outcome assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to two parallel groups. The intervention group will receive bilateral ultrasound-guided erector spinae plane block in addition to standard general anesthesia, while the control group will receive standard general anesthesia and postoperative analgesia without erector spinae plane block.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anesthesiology

Study Record Dates

First Submitted

March 12, 2026

First Posted

March 17, 2026

Study Start (Estimated)

May 24, 2026

Primary Completion (Estimated)

May 24, 2027

Study Completion (Estimated)

June 25, 2027

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared due to institutional data protection policies and ethical considerations regarding patient confidentiality

Locations